CDK7 inhibition augments the response against multidrug chemotherapy in pancreatic cancer

Siyuan Zeng(Universitätsklinikum Erlangen), Christian Pilarsky(Universitätsklinikum Erlangen)
Research Square
February 16, 2022
10.21203/rs.3.rs-1333955/v1
Cited by 0

Related Papers

Chemoresistance in Pancreatic Cancer
|International Journal of Molecular Sciences|2019|617
Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis
|BMC Cancer|2010|44
CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer
|Journal of Experimental & Clinical Cancer Research|2022|25
Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer
|Cancers|2023|14
Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer
|Cell Death Discovery|2024|6